(Q35668756)

9 August 2017

1 reference

title

Oral antivirals for the acute treatment of recurrent herpes labialis (English)

1 reference

9 August 2017

Lori A Jensen

1

1 reference

9 August 2017

James D Hoehns

series ordinal

2

1 reference

9 August 2017

Cindy L Squires

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

13 February 2004

1 reference

Annals of Pharmacotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

38

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

705-709

1 reference

Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial

9 August 2017

cites work

1 reference

The Natural History of Recurrent Facial-Oral Infection with Herpes Simplex Virus

21 January 2018

1 reference

Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials

21 January 2018

1 reference

Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group

21 January 2018

1 reference

Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Treatment of recurrent herpes simplex labialis with oral acyclovir

21 January 2018

1 reference

High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies

21 January 2018

1 reference

Valacyclovir in the treatment of facial herpes simplex virus infection

21 January 2018

1 reference

Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial

21 January 2018

1 reference

21 January 2018

Herpes simplex viruses

1 reference

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D285

1 reference

9 August 2017

1 reference